retatrutide phase 2 results weight loss Before & After: What to Expect Week by Week Retatrutide UK | The Ultimate

I can definitely tell that this is helping

Research has suggested GLP-1s may reduce the risk of heart attack and stroke in people with diabetes or obesity

This was ordered by out PCPDo we need to see a weight mgmt doc Mayada Ismail

Common Side Effects: The most common side effects are related to your digestive system

It found that semaglutide: Lowered the risk of major kidney problems by 24%5 Slowed down the progression of kidney disease Reduced the risk of heart issues by 18% Decreased the overall risk of death by 20% Real-World Results Studies of people using these medications in everyday life have also shown promising results: In Scandinavia, people using GLP-1 agonists had a 24% lower risk of serious kidney problems compared to those using other diabetes medications

These arent clinical problems